Raymond James & Associates’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,250
| Closed | -$342K | – | 3833 |
|
|
2023
Q2 | $342K | Sell |
8,250
-7,578
| -48% | -$314K | ﹤0.01% | 3135 |
|
|
2023
Q1 | $952K | Sell |
15,828
-726
| -4% | -$43.7K | ﹤0.01% | 2468 |
|
|
2022
Q4 | $1.21M | Sell |
16,554
-1,140
| -6% | -$83.6K | ﹤0.01% | 2314 |
|
|
2022
Q3 | $1.34M | Sell |
17,694
-792
| -4% | -$60.2K | ﹤0.01% | 2213 |
|
|
2022
Q2 | $1.29M | Sell |
18,486
-3,327
| -15% | -$231K | ﹤0.01% | 2285 |
|
|
2022
Q1 | $1.81M | Sell |
21,813
-854
| -4% | -$70.7K | ﹤0.01% | 2195 |
|
|
2021
Q4 | $1.7M | Buy |
22,667
+3,463
| +18% | +$260K | ﹤0.01% | 2277 |
|
|
2021
Q3 | $2.23M | Buy |
19,204
+824
| +4% | +$95.7K | ﹤0.01% | 2018 |
|
|
2021
Q2 | $4.08M | Buy |
18,380
+1,777
| +11% | +$394K | ﹤0.01% | 1624 |
|
|
2021
Q1 | $2.2M | Sell |
16,603
-40,215
| -71% | -$5.32M | ﹤0.01% | 1946 |
|
|
2020
Q4 | $9.83M | Buy |
56,818
+37,836
| +199% | +$6.55M | 0.01% | 958 |
|
|
2020
Q3 | $2.11M | Sell |
18,982
-5,726
| -23% | -$637K | ﹤0.01% | 1731 |
|
|
2020
Q2 | $1.47M | Buy |
24,708
+7,550
| +44% | +$448K | ﹤0.01% | 1909 |
|
|
2020
Q1 | $1.16M | Sell |
17,158
-1,479
| -8% | -$99.6K | ﹤0.01% | 1883 |
|
|
2019
Q4 | $1.57M | Buy |
18,637
+2,897
| +18% | +$244K | ﹤0.01% | 1982 |
|
|
2019
Q3 | $1.18M | Buy |
15,740
+10,637
| +208% | +$795K | ﹤0.01% | 2099 |
|
|
2019
Q2 | $323K | Buy |
5,103
+201
| +4% | +$12.7K | ﹤0.01% | 2946 |
|
|
2019
Q1 | $236K | Sell |
4,902
-2,211
| -31% | -$106K | ﹤0.01% | 3107 |
|
|
2018
Q4 | $238K | Buy |
7,113
+1,714
| +32% | +$57.4K | ﹤0.01% | 2997 |
|
|
2018
Q3 | $283K | Buy |
+5,399
| New | +$283K | ﹤0.01% | 3051 |
|